167 related articles for article (PubMed ID: 35405577)
1. HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma.
Chen M; Shu G; Lv X; Xu X; Lu C; Qiao E; Fang S; Shen L; Zhang N; Wang J; Chen C; Song J; Liu Z; Du Y; Ji J
Biomaterials; 2022 May; 284():121512. PubMed ID: 35405577
[TBL] [Abstract][Full Text] [Related]
2. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
[TBL] [Abstract][Full Text] [Related]
3. Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.
He C; Sun XP; Qiao H; Jiang X; Wang D; Jin X; Dong X; Wang J; Jiang H; Sun X
Cancer Sci; 2012 Mar; 103(3):528-34. PubMed ID: 22145922
[TBL] [Abstract][Full Text] [Related]
4. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
6. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
[TBL] [Abstract][Full Text] [Related]
7. Monodisperse CaCO
Chen M; Guo X; Shen L; Ding J; Yu J; Chen X; Wu F; Tu J; Zhao Z; Nakajima M; Song J; Shu G; Ji J
Int J Biol Macromol; 2023 Mar; 231():123160. PubMed ID: 36610575
[TBL] [Abstract][Full Text] [Related]
8. Nanoscale CaO
Wang Y; He X; Zhou C; Bai Y; Li T; Liu J; Ju S; Wang C; Xiang G; Xiong B
Acta Biomater; 2022 Dec; 154():536-548. PubMed ID: 36241014
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of ion-exchange porous polyvinyl alcohol microspheres as a potential drug delivery embolization system.
Li X; Ji X; Chen K; Yuan X; Lei Z; Ullah MW; Xiao J; Yang G
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111889. PubMed ID: 33579501
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
Ma P; Chen J; Qu H; Li Y; Li X; Tang X; Song Z; Xin H; Zhang J; Nai J; Li Z; Wang Z
Drug Deliv; 2020 Dec; 27(1):1412-1424. PubMed ID: 33096947
[TBL] [Abstract][Full Text] [Related]
11. Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.
Liu L; Xu X; Liang X; Zhang X; Wen J; Chen K; Su X; Ma Y; Teng Z; Lu G; Xu J
J Colloid Interface Sci; 2021 Jun; 591():211-220. PubMed ID: 33609893
[TBL] [Abstract][Full Text] [Related]
12. Drug-Eluting Porous Embolic Microspheres for Trans-Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer.
Amoyav B; Bloom AI; Goldstein Y; Miller R; Sharam M; Fluksman A; Benny O
Adv Healthc Mater; 2023 Dec; 12(30):e2301548. PubMed ID: 37315950
[TBL] [Abstract][Full Text] [Related]
13. Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy.
Lym JS; Nguyen QV; Ahn da W; Huynh CT; Jae HJ; Kim YI; Lee DS
Acta Biomater; 2016 Sep; 41():253-63. PubMed ID: 27184404
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo-Immuno-Embolization for the Treatment of Hepatocellular Carcinoma.
Kim H; Choi B; Mouli SK; Choi H; Harris KR; Kulik LM; Lewandowski RJ; Kim DH
Adv Healthc Mater; 2023 Oct; 12(26):e2300906. PubMed ID: 37163283
[TBL] [Abstract][Full Text] [Related]
15. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.
Elkhadragy L; Khabbaz RC; Muchiri RN; Totura WM; Samuelson JP; Whiteley HE; van Breemen RB; Lokken RP; Gaba RC
J Vasc Interv Radiol; 2022 Oct; 33(10):1213-1221.e5. PubMed ID: 35850455
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma.
Lei HW; Huang BR; Cai J; Li CM; Shang CB; Liao ZY; Wan ZD
Kaohsiung J Med Sci; 2022 Aug; 38(8):781-789. PubMed ID: 35467082
[TBL] [Abstract][Full Text] [Related]
18. Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours.
Alregib AH; Tan HY; Wong YH; Kasbollah A; Wong EH; Abdullah BJJ; Perkins AC; Yeong CH
J Labelled Comp Radiopharm; 2023 Aug; 66(10):308-320. PubMed ID: 37287213
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia as a target for drug combination therapy of liver cancer.
Bowyer C; Lewis AL; Lloyd AW; Phillips GJ; Macfarlane WM
Anticancer Drugs; 2017 Aug; 28(7):771-780. PubMed ID: 28542038
[TBL] [Abstract][Full Text] [Related]
20. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.
Cao MQ; You AB; Cui W; Zhang S; Guo ZG; Chen L; Zhu XD; Zhang W; Zhu XL; Guo H; Deng DJ; Sun HC; Zhang T
FASEB J; 2020 Apr; 34(4):5892-5905. PubMed ID: 32157720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
